Cancer News and Research

Latest Cancer News and Research

Individualized MicroNutrient Testing for patients

In response to the current trend toward personalized medicine, the Beaumont Weight Control Center, affiliated with Beaumont Hospitals, a major Detroit-area health system, now offers individualized MicroNutrient Testing for patients.

31 Oct 2009

Research suggests the possibility of an effective treatment for Hendra virus infections in humans

A scientific team from CSIRO and the US has demonstrated that administering human monoclonal antibodies after exposure to Nipah virus, which is closely related to Hendra virus, protected animals from challenge in a disease model.

31 Oct 2009

Public concern can undermine flu vaccination campaigns

The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines.

31 Oct 2009

Hyperthermia therapy delivered through BSD Medical's system improves survival rate for bladder cancer patients

BSD Medical Corporation today announced that published study results demonstrated improvement in overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy, delivered using the BSD-2000 Hyperthermia System, to the standard treatment regimen for 45 patients with high-risk bladder cancer.

30 Oct 2009

NIH awards Charles Drew University $9.8M to reduce cancer health disparities in underserved populations

Charles Drew University has been awarded $9.8 million from three major national funders to support the university's long-term, UCLA partnership aimed at reducing the risk of cancer among minorities in poor and disadvantaged communities.

30 Oct 2009

Cosmetic pesticides cause cancer, CCSBCY calls for government action

The Canadian Cancer Society B.C. and Yukon is calling on the provincial government to accelerate its plans and initiate a defined and timely public consultation on the use of cosmetic chemical pesticides to protect public health and the environment by the end of this year.

30 Oct 2009

Government to decide on payment for doctors who use medical-imaging

The government is weighing whether to cut Medicare payments to physicians who use medical-imaging machines to screen patients for diseases like cancer and heart problems. The decision could come as early as Friday. Lawmakers and the Centers for Medicare and Medicaid Services see the cuts as a way to prevent overuse of the technology, which drives up health care costs.

30 Oct 2009

sanofi-aventis reports financial results for the third quarter of 2009

In the third quarter of 2009, sanofi-aventis generated net sales of euro 7,400 million, up 8.0% on a reported basis. Exchange rate movements had a favorable effect of 2.0 percentage points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies.

30 Oct 2009

PIMCO Foundation awards grants to 30 US charities and community organizations

The PIMCO Foundation, the charitable arm of the Newport Beach-based money management firm PIMCO, today announced it has awarded $549,375 in 2009 grants to 30 US charities and community organizations.

30 Oct 2009

Cancer patients in northern Portugal to gain access to advanced cancer treatments

Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the Instituto Portugues Oncologia, IPO Porto.

30 Oct 2009

Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial

Sunesis Pharmaceuticals, Inc. today reported that it has completed enrollment in the REVEAL-1 (Response Evaluation of VorEloxin in AmL) trial, a Phase 2 dose regimen optimization trial of single agent voreloxin in newly diagnosed elderly acute myeloid leukemia (AML) patients who are unlikely to benefit from standard induction chemotherapy. A total of 113 patients were enrolled and dosed according to one of three dosing schedules.

30 Oct 2009

New social networking site for breast cancer survivors

Breast cancer activists, survivors and supporters now have their very own online Web community to share unique experiences and insights around breast cancer. Launching this week, the new social networking site “myKomen” centers on individual and shared experiences with a disease that will afflict 200,000 women and men this year alone.

30 Oct 2009

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

A recent study by doctors at Shinshu University, School of Medicine, in Japan determined that left side grafting has lower risk to donors compared to grafts taken from the right lobe, and it appears to be the procedure of choice for adult-to-adult living donor liver transplantation (LDLT).

30 Oct 2009

Michigan residents sue State over denied access to dental healthcare

In a move aimed at forcing the State of Michigan and the Legislature to protect the rights of Michigan's most vulnerable population, including the developmentally disabled and those with minimal financial resources, a lawsuit was filed in federal court against the Granholm Administration. A class of more than 400,000 at-risk Michigan residents is suing the State for failing to uphold its legal obligations with regard to funding certain dental care services under the federal Medicaid program.

30 Oct 2009

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Oncolytics Biotech Inc. announced that a poster presentation covering updated results of a Phase II study of REOLYSIN(R) administered intravenously to patients with sarcomas metastatic to the lung will be presented at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting being held in Miami Beach, Florida on November 6th, 2009.

30 Oct 2009

Eisai reports global Phase III study results of eribulin mesylate

Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.

30 Oct 2009

ASTRO to host news briefings on top cancer research papers

The American Society for Radiation Oncology (ASTRO) will host four news briefings with accompanying live webcasts on the top cancer research papers from its 51st Annual Meeting.

30 Oct 2009

Fourth annual 'Think Pink, Practice Pink' campaign to raise awareness and support a cure for breast cancer

Henry Schein, Inc., the largest distributor of healthcare products and services to office-based practitioners, once again partnered with the American Cancer Society for the fourth annual "Think Pink, Practice Pink" campaign to raise awareness and support a cure for breast cancer.

30 Oct 2009

IGR Genomic Center awarded ISO 9001 certification

The Institut de cancérologie Gustave Roussy (IGR) France announced today that its Genomic Center has been awarded ISO 9001 certification for quality management and compliance to the highest standards of quality by Association Française de Normalisation (AFNOR), France’s national organization for standardization and certification.

30 Oct 2009

GPC establishes grants to expand knowledge about probiotics

Today, the success of the Young Investigator Grant for Probiotics Research (YIGPRO) program was confirmed with the announcement of two $50,000 grants that are available to rising young investigators in the field of probiotics. 2010 marks the third consecutive year for the grants. The grants were established by The Global Probiotics Council (GPC), a committee formed by DANONE and Yakult Honsha Co., Ltd., and are designed to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.

30 Oct 2009

Cancer News and Research

Latest Cancer News and Research

Individualized MicroNutrient Testing for patients

Research suggests the possibility of an effective treatment for Hendra virus infections in humans

Public concern can undermine flu vaccination campaigns

Hyperthermia therapy delivered through BSD Medical's system improves survival rate for bladder cancer patients

NIH awards Charles Drew University $9.8M to reduce cancer health disparities in underserved populations

Cosmetic pesticides cause cancer, CCSBCY calls for government action

Government to decide on payment for doctors who use medical-imaging

sanofi-aventis reports financial results for the third quarter of 2009

PIMCO Foundation awards grants to 30 US charities and community organizations

Cancer patients in northern Portugal to gain access to advanced cancer treatments

Sunesis Pharmaceuticals enrolls 113 patients in voreloxin REVEAL-1 trial

New social networking site for breast cancer survivors

Left side grafting has lower risk to donors; small graft size not the only cause of 'small-for-size graft syndrome'

Michigan residents sue State over denied access to dental healthcare

Updated results from Oncolytics Biotech's Phase II study of REOLYSIN presented at CTOS meeting

Eisai reports global Phase III study results of eribulin mesylate

ASTRO to host news briefings on top cancer research papers

Fourth annual 'Think Pink, Practice Pink' campaign to raise awareness and support a cure for breast cancer

IGR Genomic Center awarded ISO 9001 certification

GPC establishes grants to expand knowledge about probiotics

Understanding the DNA Damage Response in Innate Immunity eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in